PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
about
Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis CSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisT-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significanceHepatitis B Virus Immunopathology, Model Systems, and Current TherapiesCancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice modelChronic thoracic spinal cord injury impairs CD8+ T-cell function by up-regulating programmed cell death-1 expression.Hepatitis B virus: new therapeutic perspectives.The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.microRNA-4717 differentially interacts with its polymorphic target in the PD1 3' untranslated region: A mechanism for regulating PD-1 expression and function in HBV-associated liver diseases.Present and future therapies of hepatitis B: From discovery to curePD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κBChronic hepatitis B: what should be the goal for new therapies?Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic VaccinationMaternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance.Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis.Altered Maturation Status and Possible Immune Exhaustion of CD8 T Lymphocytes in the Peripheral Blood of Patients Presenting With Acute Coronary Syndromes.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics.Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses.How to achieve immune control in chronic hepatitis B?Modeling hepatitis B virus infection, immunopathology and therapy in mice.Chronic hepatitis B: A wave of new therapies on the horizon.Immunotherapy in hepatocellular carcinoma: Primed to make a difference?Review article: novel therapies for hepatitis B virus cure - advances and perspectives.Novel targets for hepatitis B virus therapy.Immune Evasion Strategies during Chronic Hepatitis B and C Virus InfectionHepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Mechanisms of Hepatitis B Virus Persistence.Cure Strategies for Hepatitis B Virus: The Promise of Immunotherapy.Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice.Molecular mechanisms of HBeAg in persistent HBV infection.Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection.Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection.Hepatitis B cure: From discovery to regulatory approval.HBV Core Protein Enhances Cytokine Production.Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
P2860
Q26773283-631F9A37-B47C-4A31-AD92-31B750AE03B8Q28074434-7E6BF5AA-ECFF-449F-A1F0-6985CA240C89Q28083810-1038D9AE-DB20-42E1-96E2-B31D83BC12C2Q33559657-13591DF7-A68A-48C4-8D0A-1AC973F716E8Q33731047-4393CBAF-B13E-41B2-8C4D-D0ABE23C1AF7Q33853605-A5DF6956-51D5-439D-89AB-186C868E51A6Q33927761-FC7067D4-0763-4DA3-AD46-924CCAFBBCF3Q34505107-88AC24EF-0C83-4E55-A674-4001B124B8EFQ34507250-9AE2A3B9-0BDC-4246-9027-D66E7B2D00D2Q35136610-2E1957AE-19D5-4AAF-9A7C-90B6A18B1AC0Q36326288-C25A8168-874E-4733-9FF1-A42398DF3B20Q36378278-E2A03FA7-0091-4FDE-827C-009F684E011CQ36471523-B37AF4E3-3F88-4139-BA3F-0E88E799DF3EQ36769986-E2DC1A77-C67B-4452-9651-8CFD0497A847Q36776755-0FD3680D-9FCB-45D3-87E8-7A44924C8E6FQ36913522-A8712628-8AEC-4B93-9379-29EE2D848E49Q36949899-4F05A6CE-BDAB-4385-87EC-C67807EC3747Q36997987-70E1B833-FBB3-4744-AC6F-B33D4AA9FBFFQ37365537-666420B3-74CE-4D9E-B098-5FA1CBB311CAQ37406571-FCC07BDD-985E-43D7-89AA-9C4745962E1DQ37660410-6C2733DE-7C84-4BFE-8F9D-0EF739596522Q38121577-17FC57B8-E3F4-4A68-B80E-403B9A6DBB25Q38383489-0A95BD61-666F-4957-BFEB-3F51E41B9BA5Q38534533-C8330F3B-4565-4E23-B96E-CDF57D6E4B10Q38538107-C38D87E3-C885-47FE-9911-862C06BF1EC1Q38625948-A465AD64-A7A4-4BCA-9E65-AA84CE965B2DQ38865511-75D2D513-C41C-4014-BA04-E3346718BB7AQ39067316-4E37B834-F968-4B7D-8DE0-2FF7657F7558Q39327457-5786824D-DBDE-48AA-8354-DF9992B1C228Q39401740-3AAD1FDB-CDB7-4B64-8E57-40D221A1ACBCQ39425755-FAE046CD-CDC3-4338-9291-5F23FB5E62EEQ40077350-149B277D-41CF-4E71-9B3C-4D0C400961A3Q40306554-994E9618-15FC-4DEE-B0C8-5A51AD9A8A98Q40605540-D5EC3096-2CB7-4190-A148-9E1B7D9BC476Q40669256-17C8F4C7-785D-4CA0-AE17-000A4977BCE8Q41856139-D6853D16-B5F8-4363-B975-E571E3654B5CQ41923721-94B50E66-69DC-4373-9F3D-0DFB2EA4A674Q41952398-E9EE690A-1874-4EE5-AD4B-305B82D37937Q42121965-4AC24122-1647-4BEA-A77A-2B2196555FCFQ43435087-E743EF08-1F08-491A-BF2D-0C023B52D955
P2860
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@ast
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@en
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@nl
type
label
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@ast
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@en
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@nl
prefLabel
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@ast
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@en
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@nl
P2093
P2860
P1433
P1476
PD-1 blockage reverses immune ...... tence in a mouse animal model.
@en
P2093
Horng-Tay Tzeng
Hsiu-Jung Liao
Hwei-Fang Tsai
Lieping Chen
Pei-Jer Chen
Ping-Ning Hsu
Yi-Jiun Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0039179
P407
P577
2012-06-22T00:00:00Z